<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1 INDICATIONS AND USAGE<BR>               <BR>               <BR>                  <BR>                     <BR>                        Risperidone is an atypical antipsychotic agent indicated for: <BR>                        <BR>                           Treatment of schizophrenia in adults (1.1)    <BR>                           Alone, or in combination with lithium or valproate, for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults (1.2)    <BR>                           Treatment of irritability associated with autistic disorder in children and adolescents aged 5 to 16 years (1.3)    <BR>                           <BR>                              Due to Janssen Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with schizophrenia or bipolar mania. (1.1, 1.2)<BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.1 Schizophrenia<BR>                     <BR>                        <BR>Adults<BR> <BR>Risperidone is indicated for the acute and maintenance treatment of schizophrenia [see Clinical Studies (14.1)].<BR> <BR>Adolescents<BR> <BR><BR>                        Due to Janssen Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with schizophrenia. Pediatric use information for the treatment of pediatric patients with schizophrenia, 13 to 17 years of age, is approved for Janssen Pharmaceuticals Corporation’s risperidone drug products.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.2 Bipolar Mania<BR>                     <BR>                        <BR>Monotherapy – Adults and Pediatrics<BR> <BR>Risperidone is indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in adults [see Clinical Studies (14.2)].<BR> <BR><BR>                        Due to Janssen Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with bipolar mania. Pediatric use information for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age, is approved for Janssen Pharmaceuticals Corporation’s risperidone drug products.<BR>                        <BR> <BR>Combination Therapy – Adults<BR> <BR>The combination of risperidone with lithium or valproate is indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder [see Clinical Studies (14.3)].          <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     1.3 Irritability Associated with Autistic Disorder<BR>                     <BR>                        <BR>Pediatrics<BR> <BR>Risperidone is indicated for the treatment of irritability associated with autistic disorder in children and adolescents aged 5 to 16 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods [see Clinical Studies (14.4)].<BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>